Claims for Patent: 5,560,903

Summary for Patent: 5,560,903

Title:	Method of enhancing paramagnetism in chelates for MRI
Abstract:	A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more central ion or ions of an element with an atomic number of 21 to 29, 42, 44 or 57 to 83 and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
Inventor(s):	Gries; Heinz (Berlin, DE), Rosenberg; Douwe (Berlin, DE), Weinmann; Hanns-Joachim (Berlin, DE), Speck; Ulrich (Berlin, DE), Mutzel; Wolfgang (Berlin, DE), Hoyer; Georg-Alexander (Berlin, DE), Pfeiffer; Heinrich (Berlin, DE), Renneke; Franz-Josef (Berlin, DE)
Assignee:	Schering Aktiengesellschaft (Berlin, DE)
Application Number:	08/462,681
Patent Claims:	1. A method of maintaining the paramagnetism of a paramagnetic ion and simultaneously rendering it physiologically compatible, comprising chelating the ion with a ligand which is an acyclic or cyclic complexing agent containing organic nitrogen, phosphorous, oxygen or sulfur, the ion being an ion of a lanthanide element of atomic numbers 57-70 or of a transition metal of atomic numbers 21-29, 42, or 44. 2. A method of maintaining sufficient paramagnetism of a paramagnetic ion and simultaneously rendering it physiologically compatible and effective to enhance NMR imageability of a patient, comprising chelating the ion with a ligand which is an acyclic or cyclic complexing agent containing organic nitrogen, phosphorous, oxygen or sulfur, the ion being an ion of a lanthanide element of atomic numbers 58-70 or of a transition metal of atomic numbers 21-29, 42 or 44. 3. A method of maintaining sufficient paramagnetism of a paramagnetic ion and simultaneously rendering it physiologically compatible and effective to enhance NMR imageability of a patient, comprising chelating the ion with a chelating agent to form a physiologically compatible chelate complex of the paramagnetic ion. 4. A method of claim 3, further comprising formulating the complex together with a pharmaceutically acceptable carrier to prepare a pharmaceutical agent. 5. A method of claim 3, wherein said ion is an element of atomic numbers 58-70. 6. A method of claim 3, wherein said ion is an element of atomic numbers 21-29, 42 or 44. 7. A method of claim 3, wherein the paramagnetic ion is Gd(III). 8. A method of claim 3, wherein the paramagnetic ion is Mn(II). 9. A method of claim 3, wherein the paramagnetic ion is iron. 10. A method of claim 3, wherein the paramagnetic ion is chelated by an aminopolycarboxylic acid. 11. A method of claim 3, wherein no free acid or free base groups are present in the chelate complex. 12. A method of claim 3, wherein a free acid or a free base group is present in the chelate complex. 13. A method of claim 3, wherein a free acid or a free base group of the chelate complex is in time form of a salt thereof with an inorganic or organic base or acid. 14. A method of claim 3, wherein the paramagnetic ion is chelated by an open-chain chelating agent. 15. A method of claim 3, wherein the paramagnetic ion is chelated by a cyclic chelating agent. 16. A method of claim 3, wherein said chelate complex is both a salt of said paramagnetic ion and the chelate complexing agent thereof, and also a salt with an inorganic or organic base or acid. 17. A method of claim 3, wherein said chelate complex is only a salt of said paramagnetic ion and the chelate complexing agent thereof and not also a salt with an inorganic or organic base or acid. 18. A method of claim 3, wherein the chelate complex molecule consists of a single paramagnetic ion chelated by a chelating agent which optionally is a salt with an inorganic or organic base or acid. 19. A method of claim 3, wherein the chelate complex is not bound to a protein. 20. A method of claim 3, wherein the paramagnetic ion is Fe(II). 21. A method of claim 3, wherein said physiological compatibility is for a human. 22. A method of claim 3, wherein the chelate complex is nonionic. 23. A method of claim 4, wherein said agent contains 5-250 mmole/l of said chelate complex. 24. A method of claim 4, wherein said agent has a pH of 6.5-8.0. 25. A method of claim 4, wherein said agent is suitable for oral administration. 26. A method of claim 4, wherein said agent is suitable for neural administration. 27. A method of claim 4, wherein said agent is suitable for intravascular administration. 28. A method of claim 4, wherein said agent is isotonic with respect to blood. 29. A method of claim 4, wherein said agent is an aqueous solution. 30. A method of claim 4, wherein said chelate complex is water soluble.